Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 46.9 TWD Market Closed
Market Cap: 4.2B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Gross Margin
Maxigen Biotech Inc

69.7%
Current
62%
Average
31.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
69.7%
=
Gross Profit
434.9m
/
Revenue
623.8m

Gross Margin Across Competitors

Country TW
Market Cap 4.2B TWD
Gross Margin
70%
Country FR
Market Cap 181.7B EUR
Gross Margin
74%
Country UK
Market Cap 114.1B GBP
Gross Margin
0%
Country IN
Market Cap 5.5T INR
Gross Margin
52%
Country UK
Market Cap 34.9B GBP
Gross Margin
62%
Country DE
Market Cap 27.8B EUR
Gross Margin
58%
Country US
Market Cap 26.9B USD
Gross Margin
72%
Country JP
Market Cap 3T JPY
Gross Margin
38%
Country IN
Market Cap 1.1T INR
Gross Margin
56%
Country IN
Market Cap 895.9B INR
Gross Margin
49%
Country US
Market Cap 9.9B USD
Gross Margin
35%
No Stocks Found

Maxigen Biotech Inc
Glance View

Market Cap
4.2B TWD
Industry
Consumer products

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Intrinsic Value
30.4 TWD
Overvaluation 35%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
69.7%
=
Gross Profit
434.9m
/
Revenue
623.8m
What is the Gross Margin of Maxigen Biotech Inc?

Based on Maxigen Biotech Inc's most recent financial statements, the company has Gross Margin of 69.7%.